|
Condition-Based Measures |
|
Asthma |
· Use of Appropriate Medications for People with Asthma: Percentage of asthma eligible patients who appropriately prescribed medication during the measurement year |
|
Chronic Obstructive Pulmonary Disease (COPD) |
· Preventive Measures Only
· Percentage of COPD eligible patients who were assessed for: Tobacco Use, Assistance with Tobacco Cessation, Influenza Vaccination, and Pneumococcal Vaccination |
|
Diabetes |
· Comprehensive Diabetes Care: Percentage of diabetes eligible patients receiving Comprehensive Diabetes Care*
*Comprehensive diabetes care encompasses the following assessments:
|
· Hemoglobin A1c (HbA1c ) testing
· HbA1c poor control (>9.0%)
· HbA1c control (<8.0%)
· HbA1c control (<7.0%) |
· Eye exam (retinal) performed
· LDL-C screening performed
· LDL-C control (<100mg/dL)
· Medical attention for nephropathy
|
|
|
Congestive Heart Failure (CHF) |
· Preventive Measures Only
· Percentage of Heart Failure eligible patients who were assessed for: Tobacco Use, Assistance with Tobacco Cessation, Influenza Vaccination, and Pneumococcal Vaccination |
|
Ischemic Vascular Disease (IVD)
|
· Cholesterol Management for People with Ischemic Vascular Disease: Percentage of IVD eligible patients who had a LDL-C screening and maintained their LDL-C level <100mg/dL during the measurement year
· Persistence of Beta Blocker Treatment after a Heart Attack: Percentage of AMI eligible patients who received persistent beta-blocker treatment for at least six months after discharge
· Aspirin or other Antithrombotic Use by People with Ischemic Vascular Disease: Percentage of IVD eligible patients who were recommended daily aspirin use during the 12 month measurement period |
|
Preventive Measures |
|
Tobacco Use |
· Assessing Tobacco Use: Percentage of the eligible population who were asked about their use of tobacco products
· Assistance with Tobacco Cessation: Percentage of the eligible population who received the following components of this measure.
· Advising to Quit: Percentage of members 18 years of age and older who were current smokers, who were seen by a practitioner or qualified DM representative during the measurement year and who received advice on tobacco use cessation
· Discussing Cessation Strategies: Percentage of members 18 years of age and older who were current tobacco users, for whom cessation methods or strategies were recommended or discussed |
|
Influenza Vaccination |
· Influenza Vaccination: Percentage of the eligible population who have received an influenza vaccine |
|
Pneumococcal Vaccination |
· Pneumococcal Vaccination: Percentage of the eligible population who have received an pneumococcal vaccine |